advertisement

Topcon

Editors Selection IGR 16-4

Comment by: Anjali Bhorade on:
60588 Severity of vision loss interacts with word-specific features to impact out-loud reading in glaucoma
Mathews PM; Rubin GS; McCloskey M et al.
Investigative Ophthalmology and Visual Science 2015; 56: 1537-1545


Comment by: David Friedman on:
60354 Severity of Vision Loss Interacts with Word-Specific Features to Impact Out-Loud Reading in Glaucoma
Mathews PM; Rubin GS; McCloskey M et al.
Investigative Ophthalmology and Visual Science 2015; 0:


Comment by: Tin Aung & Sameer Trikha on:
60496 Morphometry of the trabecular meshwork in vivo in a healthy population using fourier-domain optical coherence tomography
Fernández-Vigo JI; García-Feijóo J; Martínez-de-la-Casa JM et al.
Investigative Ophthalmology and Visual Science 2015; 56: 1782-1788


Comment by: John Liu on:
60318 Implantation of a novel telemetric intraocular pressure sensor in patients with glaucoma (ARGOS study): 1-year results
Koutsonas A; Walter P; Roessler G et al.
Investigative Ophthalmology and Visual Science 2015; 56: 1063-1069


Comment by: Tony Realini on:
60367 Automated Detection and Quantification of Circadian Eye Blinks Using a Contact Lens Sensor
Gisler C; Ridi A; Hennebert J et al.
Translational vision science & technology 2015; 4: 4


Comment by: Don Budenz on:
60796 The Effect of Stimulus Size on the Reliable Stimulus Range of Perimetry
Gardiner SK; Demirel S; Goren D et al.
Translational vision science & technology 2015; 4: 10


Comment by: Chris Johnson on:
60424 Modifying the Conventional Visual Field Test Pattern to Improve the Detection of Early Glaucomatous Defects in the Central 10°
Ehrlich AC; Raza AS; Ritch R et al.
Translational vision science & technology 2014; 3: 6


Comment by: Paul Kaufman on:
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Tanihara H; Inoue T; Yamamoto T et al.
Acta Ophthalmologica 2015; 93: e254-e260


Comment by: Carol Toris on:
60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kiel JW; Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151


Comment by: Tina Wong on:
60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN; Ong T; Scassellati Sforzolini B et al.
British Journal of Ophthalmology 2015; 99: 738-745


Comment by: Tina Wong on:
60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Lambert WS; Carlson BJ; van der Ende AE et al.
Translational vision science & technology 2015; 4: 1


Comment by: Jonathan Crowston on:
60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Lindsey JD; Duong-Polk KX; Hammond D et al.
Neurobiology of Aging 2015; 0:


Comment by: Keith Martin on:
60189 A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial
Garcia-Medina JJ; Garcia-Medina M; Garrido-Fernandez P et al.
Acta Ophthalmologica 2015; 93: 546-554


Comment by: Michael Boland on:
59872 Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan
Hwang DK; Liu CJ; Pu CY et al.
JAMA ophthalmology 2014; 132: 1446-1452




Click on a heading to see or hide the available comments.
Click on a comment to view that comment or click on an abstract number to view the full abstract.
Click on the next page icon on the right to start reading the Editor's Selection from the first comment and on.

Issue 16-4

Change Issue


advertisement

Oculus